| Name | Title | Contact Details |
|---|
In 2010, Yogen Dalal, after being diagnosed, co-founded Glooko with the mission to make diabetes management easier by liberating data from diabetes devices to help patients and providers to make smarter decisions.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Ascent Solutions is a company that provides native Salesforce apps for ERP, inventory, rentals, labels, and omnichannel orders that provide Operations 360 on the platform.
Founded in Detroit in early 2003 and staffed by digital strategists, advanced business insight analysts, technology infrastructure architects, and creative and web designers, 118id is focused on developing and delivering world-class technology and strategy solutions.
Cumula 3 Group helps clients license, implement and optimize NetSuite solutions.